|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
AUGS-IUGA 2014 Scientific Meeting Late Breaking Abstract Submission Opens April 30th
Late-breaking abstract submissions are intended to allow for the timely presentation of high impact trials to AUGS-IUGA meeting attendees. It is expected that these abstract submissions are from studies for which no preliminary data was available at the time of the abstract submission deadline (February 3, 2014).
This meeting feature is not a mechanism to update previously submitted preliminary data or to provide an opportunity for previously rejected abstracts to be revised and resubmitted for consideration.
Abstract submission will open on April 30 and will close on June 2. For additional details and submission guidelines, please visit the meeting website.
| Share this article:
President's Perspective: Power Morcellation for Fibroids
On April 17, 2014, the Food and Drug Administration released a communication regarding uterine power morcellation in hysterectomy and myomectomy. The FDA discouraged the use of laparoscopic power morcellation during hysterectomy or myomectomy for the treatment of women with uterine fibroids. It is important to note that this discouragement was limited to uterine fibroids.
The American College of Obstetricians and Gynecologists has posted on their website notification of their plans to undertake a thorough and deliberate review of the published scientific literature about power morcellation and malignancy in gynecologic surgery. As the College conducts its review, they are evaluating the incidence of undiagnosed uterine sarcomas. The resulting estimate will take into account variables such as sample size, age, patient risk factors, and the occurrence of malignancy.
Some AUGS members have asked if AUGS was planning to make a statement on this recent FDA safety notification. Our organization (AUGS) is awaiting the ACOG review.
Register Now for the AUGS-IUGA 2014 Scientific Meeting
Attend the AUGS-IUGA 2014 Scientific Meeting and join the largest venue for those in the field of urogynecology and Female Pelvic Medicine and Reconstructive Surgery to come together for education, networking and sharing.
Check out the latest information on Workshops and Roundtable Breakfasts before completing your registration. Be sure to register by May 11 to save!
Calling All AUGS Physician Members Working in Private Practice!
The membership of the American Urogynecologic Society (AUGS) is comprised of a diverse group of individuals working in different professional settings, such as academic centers, hospitals, and private practice. In order to ensure that AUGS is serving and meeting the needs of all membership types and professional affiliations, we are collecting information from our members.
If you currently work in private practice, AUGS wants your input on how to "maximize" your member experience. Please take a few minutes to complete the Private Practice Survey.
Please follow this link to complete the survey by Monday, April 28: https://www.surveymonkey.com/s/augsprivatepractice.
If you have any questions or comments, please contact AUGS at firstname.lastname@example.org or call (202) 367-1167.
Multicentric prospective randomized study evaluating the interest of intravaginal electro-stimulation at home for urinary incontinence
GynÃ©cologie ObstÃ©trique & FertilitÃ© via Europe PubMed
Although perineal reeducation of stress urinary incontinence is beneficial in 80 percent of cases, patients must perform self-retraining exercises of the perineal muscles at home in order to maintain the benefit of the physiotherapy. The objective of this study was to assess the benefit of GYNEFFIK, a perineal electro-stimulator, during the home-care phase. The study included women with stress urinary incontinence (UI) or with mixed UI (composed predominantly of stress UI) who had responded to physiotherapy.
Pilot study of liposome-encapsulated onabotulinumtoxinA for patients with overactive bladder: A single-center study
Intradetrusor onabotulinumtoxinA (BoNT-A) injection benefits overactive bladder (OAB) patients, but increased postvoid residual (PVR) urine volume and urinary tract infection (UTI) remain risks. To evaluate instillation of liquid liposomal BoNT-A (Lipotoxin) for the treatment of OAB and to determine its mechanism of action, researchers conducted a double-blind randomized parallel controlled pilot trial in 24 OAB patients at a single tertiary center.
Stress urinary incontinence: Usefulness of perineal ultrasound
La radiologia medica via Springer
Perineal ultrasound provides the most sensitive assessment of the degree of urethral mobility by measuring the pubo-urethral distance and angle. To evaluate whether these indices may be determinants of success in prosthetic surgery for stress urinary incontinence, we conducted a retrospective study of patients treated with tension-free vaginal tape-obturator (TVT-O) surgery and assessed, by measuring the pubo-urethral distance and angle after TVT-O, whether there was any quantitative difference between the mean values measured in the group of cured patients and uncured patients.
Urinary bacteria in adult women with urgency urinary incontinence
International Urogynecology Journal via Springer
This study's aims were to detect and quantify bacterial DNA in the urine of randomized trial participants about to undergo treatment for urinary urgency incontinence (UUI) without clinical evidence of urinary tract infection (UTI) and to determine if the presence of bacterial DNA in baseline urine relates to either baseline urinary symptoms or UTI risk after urinary tract instrumentation.
Effect of aging on storage and voiding function in women with stress-predominant urinary incontinence
International Urogynecology Journal via ScienceDirect
This study sought to investigate age related changes in urodynamic parameters in two large cohorts of women planning stress urinary incontinence (SUI) surgery. Using a standardized protocol, urodynamic parameters were obtained from participants in the SISTEr and TOMUS trials undergoing baseline non-invasive flow (NIF), followed by filling cystometrogram (CMG) and pressure flow study (PFS). Bladder Contractility Index and detrusor hypocontractility were also characterized. Excluded patients had prior SUI surgery or prolapse stage higher than 2.
Nocturnal incontinence poses major burden after female bladder reconstruction
Health-related quality of life is lower in women who have undergone radical cystectomy and neobladder reconstruction for bladder cancer than in the general female population, shows research.
Of the various procedural complications, night-time incontinence had a particularly severe and far-ranging detrimental impact on women’s QoL, the researchers report in the International Journal of Urology.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063